Treatment of Comorbid Sleep Disorders and Post Traumatic Stress Disorder (PTSD)

NCT02773693 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2018-09-27

No results posted yet for this study

Summary

The primary objective of the current study is to determine if providing cognitive-behavioral therapy of Insomnia and nightmares (CBTin) and Cognitive Processing Therapy of PTSD (CPT) results in greater PTSD and sleep symptom reduction than CPT only. A secondary objective is to determine if the sequencing of CBTl\&N before or after CPT results in differential effects on PTSD and sleep symptom reduction.

Conditions

Interventions

BEHAVIORAL

Cognitive Processing Therapy-Cognitive Only (CPT)

Twice weekly CPT over 6 weeks.

BEHAVIORAL

Cognitive Behavioral Therapy of Insomnia and Nightmares (CBTin)

Cognitive behavioral therapy of insomnia and nightmares weekly over 6 weeks.

BEHAVIORAL

Continuation Cognitive Processing Therapy-Cognitive Only (CPT)

Once weekly continuation CPT over 6 weeks.

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    collaborator OTHER
  • South Texas Veterans Health Care System

    collaborator FED
  • Duke University

    collaborator OTHER
  • Durham VA Medical Center

    collaborator FED
  • Boston VA Research Institute, Inc.

    collaborator OTHER
  • University of North Texas, Denton, TX

    lead OTHER

Principal Investigators

  • Daniel J Taylor, Ph.D. · University of North Texas Health Science Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2019-09-30
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02773693 on ClinicalTrials.gov